Your browser doesn't support javascript.
loading
Survival after secondary liver resection in metastatic colorectal cancer: Comparing data of three prospective randomized European trials (LICC, CELIM, FIRE-3).
Moehler, Markus; Folprecht, Gunnar; Heinemann, Volker; Holch, Julian Walter; Maderer, Annett; Kasper, Stefan; Hegewisch-Becker, Susanna; Schröder, Jan; Overkamp, Friedrich; Kullmann, Frank; Bechstein, Wolf Otto; Vöhringer, Matthias; Öllinger, Robert; Lordick, Florian; Geißler, Michael; Schulz-Abelius, Armin; Linz, Bernhard; Bernhard, Helga; Paul, Andreas; Schmidtmann, Irene; Potthoff, Karin; Schimanski, Carl Christoph.
Afiliação
  • Moehler M; Medical Department, University Medical Center, Johannes Gutenberg University Mainz, Mainz, Germany.
  • Folprecht G; Medical Department, University Hospital Carl Gustav Carus, Dresden, Germany.
  • Heinemann V; Department of Medical Oncology & Comprehensive Cancer Center, University Hospital Grosshadern, München, Germany.
  • Holch JW; Department of Medical Oncology & Comprehensive Cancer Center, University Hospital Grosshadern, München, Germany.
  • Maderer A; Medical Department, University Medical Center, Johannes Gutenberg University Mainz, Mainz, Germany.
  • Kasper S; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany.
  • Hegewisch-Becker S; Hematological and Oncological Practice Eppendorf (HOPE), Private Clinics for Oncology, Hamburg, Germany.
  • Schröder J; Private Clinics for Hematology and Oncology, Müllheim a.d.R., Germany.
  • Overkamp F; Oncologianova GmbH Recklinghausen, Recklinghausen, Germany.
  • Kullmann F; Department of Medicine I, Nordoberpfalz Clinics AG, Weiden i.d.O., Germany.
  • Bechstein WO; Department of General and Visceral Surgery, Frankfurt University Hospital and Clinics, Frankfurt, Germany.
  • Vöhringer M; Department of Hematology and Oncology, Robert Bosch Hospital, Stuttgart, Germany.
  • Öllinger R; Department of Surgery, Campus Charité Mitte and Campus Virchow Klinikum, Charité University Medicine, Berlin, Germany.
  • Lordick F; Department of Oncology, Gastroenterology, Hepatology, Pulmonology, and Infectious Diseases, University Cancer Center Leipzig (UCCL), University Hospital Leipzig, Leipzig, Germany.
  • Geißler M; City Hospital Karlsruhe, Karlsruhe, Germany.
  • Schulz-Abelius A; Department of Hematology and Oncology, Hospital Altenburger Land GmbH, Altenburg, Germany.
  • Linz B; Private Clinics for Hematology and Oncology Offenburg, Offenburg, Germany.
  • Bernhard H; Department of Internal Medicine 5, Hematology/Oncology, Municipal Hospital Darmstadt, Darmstadt, Germany.
  • Paul A; Department of Surgery, University Hospital Essen, Essen, Germany.
  • Schmidtmann I; Medical Department, University Medical Center, Johannes Gutenberg University Mainz, Mainz, Germany.
  • Potthoff K; Medical Department, iOMEDICO, Freiburg, Germany.
  • Schimanski CC; Medical Department, University Medical Center, Johannes Gutenberg University Mainz, Mainz, Germany.
Int J Cancer ; 150(8): 1341-1349, 2022 04 15.
Article em En | MEDLINE | ID: mdl-34807464
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Terapia Combinada / Neoplasias Hepáticas Tipo de estudo: Clinical_trials / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Int J Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Terapia Combinada / Neoplasias Hepáticas Tipo de estudo: Clinical_trials / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Int J Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha